Genevac launches next-gen evaporator

By Wai Lang Chu

- Last updated on GMT

Related tags Molecular biology Chemistry

Genevac announces the launch of a new second-generation version of
its EZ-2 centrifugal evaporator, which is able to take tubes,
flasks and vials directly from the synthesis process, providing
flexibility for those switching their compound generation
programmes from serial chemistry to parallel synthesis.

The new EZ-2 personal evaporator improves on its predecessor by extending the operational versatility and ease of use. As a result, the EZ-2 is able to evaporate solvents in typically half the time of traditional evaporator designs.

The system will accommodate a wide selection of sample holders enabling evaporation from most common sample container formats including round-bottom flasks up to 500ml, tubes up to 160mm long, custom reaction blocks and shallow or deep-well microplates.

Genevac​'s foray into the molecular biology market marks a departure for the company as its products previously had a drug discovery chemistry element.

Solvent removal tasks in biological research commonly involve ethanol, methanol, water and acetonitrile.

The second-generation system uses the established EZ-2 solvent removal platform. The system provides an evaporator primarily aimed at academic researchers and in particular molecular biologists.

Further time savings are made as users can see solvents as they collect in the trap and emptying the collection vessel is simple, requiring no defrosting.

Offering true unattended operation capability, the EZ-2 requires no user training, and users can competently use the system within five minutes.

The EZ-2 has been designed to concentrate or completely dry samples.

The EX-2 requires no peripherals for operation, the compact EZ-2 fits neatly onto a laboratory bench or into a fume hood.

Other vacuum evaporators currently on the market include the Polaron E6500 Mini High Vacuum Evaporator from Quorum Technologies and the JEE-420 vacuum evaporator from JEOL.

Related topics Preclinical Research

Related news